1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow casimersen: new trials by email Literature Review of casimersen trials Research Report on casimersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) SRP-4045, SRP-4053, Placebo - Duchenne Muscular Dystrophy | Phase 3 | Completed | Sarepta Therapeutics, Inc. | 228 | 2016-09-28 | 2025-11-18 |
Muscular Dystrophy, Duchenne (1)
Sarepta Therapeutics, Inc. (1)
Argentina (1) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Ireland (1) · Israel (1) · Italy (1)
2015 (1)